Application of nitric oxide measurements in clinical conditions beyond asthma.
2015 (English)In: European clinical respiratory journal, ISSN 2001-8525, Vol. 2Article in journal (Refereed) Published
Fractional exhaled nitric oxide (FeNO) is a convenient, non-invasive method for the assessment of active, mainly Th2-driven, airway inflammation, which is sensitive to treatment with standard anti-inflammatory therapy. Consequently, FeNO serves as a valued tool to aid diagnosis and monitoring in several asthma phenotypes. More recently, FeNO has been evaluated in several other respiratory, infectious, and/or immunological conditions. In this short review, we provide an overview of several clinical studies and discuss the status of potential applications of NO measurements in clinical conditions beyond asthma.
Place, publisher, year, edition, pages
2015. Vol. 2
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:uu:diva-279107PubMedID: 26672962OAI: oai:DiVA.org:uu-279107DiVA: diva2:907570